J Cancer 2023; 14(2):299-305. doi:10.7150/jca.80620 This issue Cite
Research Paper
1. Section of Physical Medicine & Rehabilitation, Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2. Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.
3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
4. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
5. Section of Palliative Medicine, Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Introduction: Urinary dysfunction has a strong impact clinically, socially, and economically. Although the development of acute urinary dysfunction in hospitalized patients with cancer is common in clinical practice, its occurrence and management strategies are scant in the literature. It has been reported as one of the more common medical complications in patients with cancer undergoing acute inpatient rehabilitation. This study assessed the frequency of and risk factors for acute urinary dysfunction among these patients and identified the interventions used for management.
Methods: This is a retrospective study of consecutive patients admitted to a National Cancer Institute Comprehensive Cancer Center's acute inpatient rehabilitation service from 9/1/2020 through 3/15/2021. We excluded patients that were readmissions during the study time frame. We collected patients' demographic, clinical, and functional data. We defined acute urinary dysfunction as the development of any new urinary symptom(s) or diagnosis, which involved additional work-up and/or management after admission to the acute inpatient rehabilitation service.
Results: Of the 176 total patients included in this study, 47 (27%; 95% confidence interval [CI], 20-34) patients had acute urinary dysfunction. The most frequent diagnoses were urinary tract infection (32%) and neurogenic bladder (26%). The most common tests were urine cultures (32%) and urinalyses (30%). The most commonly prescribed medications were antibiotics (32%) and alpha-1 blockers (15%). Other most frequent interventions included timed voiding (34%) and intermittent catheterization with bladder scans (28%). Acute urinary dysfunction was associated with an increased length of stay on the inpatient rehabilitation service (odds ratio [OR], 1.13; 95% CI, 1.06-1.20; P<.001), surgery during the index admission (OR, 2.50; 95% CI, 1.21-5.16; P=.014), and fecal incontinence (OR, 6.41; 95% CI, 1.83-22.44; P=.004).
Conclusion: Acute urinary dysfunction was noted to be a substantial problem in this cohort. This is an overlooked dimension of inpatient cancer rehabilitation that deserves more attention. Patients at risk for acute urinary dysfunction may benefit from close monitoring for medical management and rehabilitation interventions to maximize functional independence with bladder care. More research regarding acute urinary dysfunction types and management approaches in post-acute care settings for patients with cancer is justified.
Keywords: risk factors, inpatient, neoplasms, lower urinary tract symptoms, urinary disorders, pelvic floor
Urinary dysfunction can manifest with symptoms such as incontinence, nocturia, urgency, frequency, and urinary retention [1]. These symptoms adversely affect sleep, mood, the ability to perform the activities of daily living [2], and quality of life [3]. Urge urinary incontinence has been rated as the most bothersome symptom of urinary dysfunction among both women and men [4] and is associated with a substantial economic burden in the United States [5]. Neurogenic lower urinary tract dysfunction has been shown to be a substantial economic burden for healthcare systems worldwide [6].
Patients with cancer can develop urinary dysfunction due to their disease [7] or its treatments, such as chemotherapy, immunotherapy, pelvic radiation, or surgery [7,8]. Previous studies on urinary dysfunction primarily concentrated on a few specific cancer types and a variety of urinary dysfunction types [9-12]. Patients with cancer undergoing acute inpatient rehabilitation after hospitalization, however, have a wide variety of heterogeneous cancer types. The purpose of acute inpatient rehabilitation is to provide an intensive and a total of three hours of rehabilitation sessions per day at least five days of the week generally (or a total of fifteen hours of rehabilitation sessions over consecutive seven days) while under the management of a rehabilitation physician with weekly interdisciplinary team meetings. These sessions require the need of at least two or more therapies (i.e. physical, occupational, speech, etc.) in stable patients who can actively participate and have measurable functional improvements.
In the practice of physical medicine and rehabilitation, urinary dysfunction is often due to neurological conditions affecting the brain and spinal cord [13]. These conditions can lead to morbid urological complications, such as urinary tract infections, urinary incontinence, urolithiasis [13,14], urosepsis, ureteric obstruction, vesicoureteral reflux, and renal failure [14].
Neurological deficits and deconditioning due to cancer are common triggers for the need for acute inpatient rehabilitation [15] following hospitalization. One study assessing medical complications among patients with cancer undergoing acute inpatient rehabilitation found that 38% had genitourinary or renal disorders [16]. To our knowledge, however, acute urinary dysfunction types, occurrences, and management strategies among patients with cancer undergoing acute inpatient rehabilitation have not been studied. Therefore, this study assessed the frequency of and risk factors for acute urinary dysfunction among these patients and identified the interventions used to manage the condition. Research data in this area is essential to improving healthcare quality, especially concerning the comprehensive and interdisciplinary medical and rehabilitative management approaches.
This retrospective study was conducted with approval from the Institutional Review Board. Data were collected from the institutional electronic health records and the acute inpatient rehabilitation admissions log. The data were managed using Research Electronic Data Capture software (REDCap 12.5.9 - © 2022 Vanderbilt University). The patients admitted to M. D. Anderson's acute inpatient rehabilitation service have to be of 18 years or older and have a primary rehabilitation impairment that was associated with their cancer diagnosis or treatment-related hospital admission. This study initially comprised 181 patients with cancer who were consecutive admissions to the acute inpatient rehabilitation service from September 1, 2020, through March 15, 2021. It then excluded five patients who were readmitted again to the rehabilitation service during the study period of September 1, 2020, through March 15, 2021, to avoid duplicating patient medical record numbers. This resulted in a total cohort of 176 unique patient admissions to evaluate for this study. (It did include patients who might have had another acute inpatient rehabilitation stay before the study period since they would have unique medical record numbers to include within the study time frame).
Data collected at the time of admission for acute inpatient rehabilitation included demographic information (age, sex, race, and ethnicity) and clinical characteristics (primary neoplasm type, occurrence of surgery during the index admission). We reviewed daily rehabilitation progress notes and discharge summaries to obtain additional clinical characteristics (length of stay for acute inpatient rehabilitation, severity of cognitive deficits as determined by speech and language pathologists, presence or absence of fecal incontinence, and the urinary dysfunction details).
Functional status was measured using the Activity Measure for Post-Acute Care (AM-PAC) Inpatient “Six Clicks” Short Forms, which are validated [17] and reliable [18]. A physical therapist completed the AM-PAC basic mobility form, and an occupational therapist completed the AM-PAC daily activity form within 24 hours after admission and 24 hours before discharge from the acute inpatient rehabilitation service.
We defined acute urinary dysfunction as the development of any new urinary symptom(s) or diagnosis requiring work-up and/or management after admission to the acute inpatient rehabilitation service. Thus, any urinary dysfunction already present upon admission to the acute inpatient rehabilitation service was considered an established urinary dysfunction. We divided the total cohort into 2 groups for comparison: 1) patients with acute urinary dysfunction and 2) patients without acute urinary dysfunction (no new urinary dysfunction or established urinary dysfunction without any new urinary dysfunction).
The demographic and clinical characteristics of the study population were summarized using standard summary statistics such as medians, interquartile percentages, and ranges for continuous variables and frequencies and percentages for categorical variables. Patient characteristics were compared according to the presence or absence of acute urinary dysfunction using a t-test or Wilcoxon rank-sum test for continuous variables and a chi-squared or Fisher's exact test for categorical variables. We estimated acute and established urinary dysfunction and established 95% confidence intervals (CIs) to determine proportions and compare them. Types of urinary dysfunction were described with frequency percentages. Logistic regression models were conducted to estimate the odds of acute urinary dysfunction based on clinical, functional, and demographic variables.
Of the 176 patients included in this study, 47 (27%; 95% CI, 20-34) patients had acute urinary dysfunction during acute inpatient rehabilitation. Table 1 provides an overview of the demographic information, clinical characteristics, and functional scores for the total cohort and the subgroups with and without acute urinary dysfunction. Of note and for comparison, there were 29 (16%; 95% CI, 11-23) patients with an established urinary dysfunction. In the total cohort of 176 patients, most patients were males (59%), White (83%), and had undergone surgery (57%) during the index admission. The median age was 67, and the median length of stay on the acute inpatient rehabilitation service was 10 days. The primary neoplasm types were hematologic and lymphatic (26%) and brain and other nervous systems (21%). The acute inpatient rehabilitation length of stay was higher in the acute urinary dysfunction group (median 11 days vs. 10 days; p = 0.002). There was a higher proportion of surgery during hospitalization in the acute urinary dysfunction group (72% vs. 51%; p = 0.012). There was also a higher proportion of fecal incontinence during acute inpatient rehabilitation in the acute urinary dysfunction group (17% vs. 3%; p = 0.003). The other variables in Table 1 were not statistically significant between the two groups (acute urinary dysfunction and no acute urinary dysfunction groups).
Comparison of patients with and without acute urinary dysfunction during inpatient cancer rehabilitation
Characteristics | Total, n = 176 | Acute urinary dysfunction, n = 47 | Established/no new urinary dysfunction, n = 129 | P-valuea |
---|---|---|---|---|
Sex, n (%) | .864b | |||
Male | 103 (59) | 28 (60) | 75 (58) | |
Female | 73 (41) | 19 (40) | 54 (42) | |
Race, n (%) | .683c | |||
White | 146 (83) | 38 (81) | 108 (84) | |
Black | 15 (8) | 5 (10) | 10 (8) | |
Asian | 12 (7) | 4 (9) | 8 (6) | |
Others | 3 (2) | 0 (0) | 3 (2) | |
Ethnicity, n (%) | .502b | |||
Hispanic | 18 (10) | 6 (13) | 12 (9) | |
Non-Hispanic | 158 (90) | 41 (87) | 117 (91) | |
Primary neoplasm type, n (%) | .075c | |||
Hematologic and lymphatic | 45 (26) | 9 (19) | 36 (28) | |
Brain and other nervous systems | 37 (21) | 10 (21) | 27 (21) | |
Genitourinary system | 20 (11) | 8 (17) | 12 (9) | |
Digestive system | 15 (9) | 4 (9) | 11 (9) | |
Respiratory system | 12 (7) | 5 (11) | 7 (5) | |
Bone and connective tissue | 10 (6) | 6 (13) | 4 (3) | |
Oral cavity and pharyngeal | 10 (6) | 1 (2) | 9 (7) | |
Othersd | 27 (15) | 4 (9) | 23 (18) | |
Surgery during the index admission, n (%) | .012b | |||
Yes | 100 (57) | 34 (72) | 66 (51) | |
No | 76 (43) | 13 (28) | 63 (49) | |
Fecal incontinence, n (%) | .003c | |||
Yes | 12 (7) | 8 (17) | 4 (3) | |
No | 164 (93) | 39 (83) | 125 (97) | |
Cognitive deficits, n (%) | .077 c | |||
None | 133 (76) | 33 (70) | 100 (77) | |
Mild | 25 (14) | 7 (15) | 18 (14) | |
Moderate | 13 (7) | 3 (6) | 10 (8) | |
Severe | 5 (3) | 4 (9) | 1 (1) | |
Age in years, median (IQRe) | 67 (56, 73) | 65 (53, 70) | 68 (56, 73) | .092f |
Acute inpatient rehabilitation length of stay in days, median (IQR) | 10 (7, 14) | 11 (9, 16) | 10 (7, 13) | .002 f |
AM-PACd Basic Mobility score at admission, median (IQR) | 41 (38, 44) | 41 (35, 44) | 41 (39, 44) | .203f |
AM-PAC Daily Activity score at admission, median (IQR) | 37 (35, 40) | 36 (33, 39) | 37 (35, 40) | .071f |
AM-PAC Basic Mobility score at discharge, median (IQR) | 44 (41, 50) | 44 (39, 48) | 44 (41, 50) | .094f |
AM-PAC Daily Activity score at discharge, median (IQR) | 40 (37, 42) | 40 (36, 42) | 40 (38, 42) | .371f |
a Boldface indicates a statistically significant difference;
b Chi-squared test;
c Fisher's exact test;
d Other neoplasms included breast, endocrine, eye and orbit, skin, thymus, other soft tissue, and unspecified primary site;
e IQR = interquartile range;
f Wilcoxon rank-sum test;
g AM-PAC = Activity Measure for Post-Acute Care (Inpatient “Six Clicks” Short Form).
Acute urinary dysfunction characteristics among 47 patients with cancer undergoing inpatient rehabilitationa
Presence of acute urinary symptoms | N = 47, (100%) |
---|---|
Diagnosis/symptoms | |
Urinary tract infection | 15 (32) |
Neurogenic bladder | 12 (26) |
Acute renal insufficiency/failure | 9 (19) |
Dysuria/urinary retention that improved | 3 (6) |
Benign prostate hypertrophy exacerbation | 2 (4) |
Functional incontinence | 2 (4) |
Pelvic floor dysfunction | 2 (4) |
Post-operative urinary retention | 1 (2) |
Urinary frequency with negative work-up | 1 (2) |
Interventions | |
Test | |
Urine culture | 15 (32) |
Urinalysis | 14 (30) |
Renal function test | 6 (13) |
Renal ultrasound | 1 (2) |
Medication | |
Antibiotic for urinary tract infection | 15 (32) |
Alpha-1 blocker | 7 (15) |
Intravenous hydration | 5 (11) |
5-alpha-reductase inhibitor | 1 (2) |
Anticholinergic agent | 1 (2) |
Phenazopyridine | 1 (2) |
Consultation | |
Nephrology | 3 (6) |
Urology | 2 (4) |
Infectious diseases | 1 (2) |
Internal medicine | 1 (2) |
Procedure | |
Nephrostomy tube removal | 1 (2) |
Other | |
Timed voiding | 16 (34) |
Intermittent catheterization with bladder scans | 13 (28) |
Urethral catheter | 8 (17) |
Condom catheter | 1 (2) |
Facilitative techniques and maneuvers (massage, double voiding, standing) | 6 (13) |
Education/lifestyle advice | 5 (11) |
Pelvic rehabilitation/exercise | 1 (2) |
a Total cohort = 176 patients.
Table 2 describes the characteristics of acute urinary dysfunction with frequencies and percentages. This study had only single (not multiple) acute urinary dysfunction diagnoses per patient. The most frequent diagnoses were urinary tract infection (32%) and neurogenic bladder (26%). The most common tests were urine cultures (32%) and urinalyses (30%). The most commonly prescribed medications were antibiotics (32%) and alpha-1 blockers (15%). Other most frequent interventions included timed voiding (34%) and intermittent catheterization with bladder scans (28%).
Table 3 provides the univariate logistic regression estimates of the odds that a particular event was associated with acute urinary dysfunction. As the acute inpatient rehabilitation length of stay increased, the odds of having acute urinary dysfunction increased (OR: 1.13; 95% CI, 1.06 - 1.20; p<.001). Those who had surgery during hospitalization had 2.50 (95% CI, 1.21 - 5.16; p = .014) times the odds of having acute urinary dysfunction. Those with fecal incontinence during acute inpatient rehabilitation had 6.41 (95% CI, 1.83 - 22.44; p = .004) times the odds of having acute urinary dysfunction. The other variables in Table 3 were not statistically significant.
Univariate logistic regression estimates of the odds of acute urinary dysfunction
Characteristica | Odds ratio | 95% CI | P-valueb |
---|---|---|---|
Age | 0.98 | 0.96 - 1.01 | .141 |
Sex | |||
Female | 1.00 | 1.00 | |
Male | 1.06 | 0.54 - 2.09 | .864 |
Race | |||
White | 1.00 | 1.00 | |
Otherc | 1.22 | 0.51 - 2.89 | .655 |
Ethnicity | |||
Hispanic | 1.00 | 1.00 | |
Not Hispanic | 0.70 | 0.25 - 1.99 | .504 |
Inpatient rehabilitation length of stay | 1.13 | 1.06 - 1.20 | < .001 |
Primary neoplasm diagnosis | |||
Bone and connective tissue | 1.00 | 1.00 | .104 |
Brain and other nervous systems | 0.25 | 0.06 - 1.06 | |
Digestive system | 0.24 | 0.04 - 1.33 | |
Hematologic and lymphatic | 0.17 | 0.04 - 0.72 | |
Oral cavity and pharyngeal | 0.07 | 0.01 - 0.84 | |
Respiratory system | 0.48 | 0.09 - 2.63 | |
Genitourinary system | 0.44 | 0.09 - 2.09 | |
Othersd | 0.12 | 0.02 - 0.60 | |
Surgery during the index admission | |||
No | 1.00 | 1.00 | |
Yes | 2.50 | 1.21 - 5.16 | .014 |
Cognitive dysfunction during rehab stay | |||
No | 1.00 | 1.00 | |
Yes | 1.46 | 1.69 - 3.10 | .320 |
Level of cognitive dysfunction | |||
Mild | 1.00 | 1.00 | .177 |
Moderate | 0.77 | 0.16 - 3.66 | |
Severe | 10.29 | 0.97 - 108.81 | |
None | 0.85 | 0.33 - 2.21 | |
Fecal incontinence during rehab stay | |||
No | 1.00 | 1.00 | |
Yes | 6.41 | 1.83 - 22.44 | .004 |
AM-PACe Basic Mobility score at admission | 0.96 | 0.91 - 1.02 | .174 |
AM-PAC Daily Activity score at admission | 0.99 | 0.93 - 1.05 | .649 |
AM-PAC Basic Mobility score at discharge | 0.96 | 0.91 - 1.01 | .141 |
AM-PAC Daily Activity score at discharge | 0.98 | 0.91 - 1.04 | .441 |
a Characteristics were assessed based on a series of univariate logistic regression models with factor significance determined by the Wald Chi-Square Test;
b Boldface indicates a statistically significant difference;
c Black and Asian were combined with “Other” to make the estimation more reliable because there were few individuals in these categories;
d Other neoplasms included breast, endocrine, eye and orbit, skin, thymus, other soft tissue, and unspecified primary site cancers;
e AM-PAC = Activity Measure for Post-Acute Care (Inpatient "Six Clicks" Short Form).
In this cohort, we found a significant rate (27%) of acute urinary dysfunction among patients with cancer undergoing acute inpatient rehabilitation. Previous studies on urinary dysfunction in patients with cancer reported a variety of urinary dysfunction types affecting the quality of life [9-12]. These studies concentrated on patients with specific cancer types such as prostate, colorectal, endometrial, and ovarian cancer [9-12]. Other studies have described urinary dysfunction primarily in patients undergoing inpatient rehabilitation for strokes [19], brain disorders [20-21], spinal cord disorders [22-24], and other neurological conditions. To our knowledge, this is the first study to report the rate of acute urinary dysfunction among patients with cancer and undergoing acute inpatient rehabilitation. Identifying acute urinary dysfunction in these patients is essential because urinary symptoms can affect patients' participation in rehabilitation programs [25]. Improving patients' ability to independently manage their bladder (and bowel) function is a fundamental goal of acute inpatient rehabilitation, in addition to improving patients' physical functioning levels. If patients cannot manage their bladders adequately, urological complications can occur. Urological complications such as urolithiasis and renal failure have been reported to cause hospital readmissions shortly after discharge from acute inpatient cancer rehabilitation, increasing the 30-day readmission rate [26]. Of note, acute renal insufficiency or failure was our study's third most frequent type of acute urinary dysfunction.
Patients with cancer undergoing acute inpatient rehabilitation have a variety of impairments for which rehabilitation is needed (e.g., debility/deconditioning, medically complex conditions, and, in patients needing neurorehabilitation, brain and/or spinal cord dysfunction is common) [27]. This difference in case mix can account for the varying types of urinary dysfunction these patients experience such as urinary tract infection, neurogenic bladder, and other (see Table 2) wide variety of urinary dysfunctions. Patients with cancer are often transferred to the acute inpatient rehabilitation service with an external urethral catheter in place, and removal of the urethral catheter during acute inpatient rehabilitation may lead to a new diagnosis of acute urinary dysfunction. Patients undergoing neurorehabilitation are at increased risk for significant urological complications due to neurological conditions that may be severe and/or permanent. For example, in our patient cohort, the 12 individuals diagnosed with a neurogenic bladder included 8 patients who had undergone spinal surgery for metastatic spinal cord compression; 1 who had undergone a sacral chordoma resection; 1 who had undergone a hemipelvectomy due to osteosarcoma; 1 with pelvic sarcoma; and 1 with bladder detrusor underactivity.
The most frequent diagnoses in our cohort were urinary tract infection (32%) and neurogenic bladder (26%), both of which are also common in patients with spinal cord injuries [28]. Urinary tract infections are a common source of morbidity among patients undergoing rehabilitation for spinal cord injuries [23]. Moreover, studies of patients undergoing neurorehabilitation for stroke, brain, and spinal cord disorders have demonstrated that decreased functional scores are associated with urinary tract infections [29-31]. In our study, there was no statistical significance in the functional scores between the patients with and without acute urinary dysfunction (see Table 1). This may be related to the fact that our patients were treated in an acute care hospital in which diagnosis and management are rapid and resources for investigations and consultations are readily available; these facility characteristics improve patients' chances of achieving maximal functional recovery. Access to this level of care may not be available at free-standing rehabilitation facilities physically disconnected from a hospital.
The most frequently ordered tests for the development of new urinary symptoms were urine cultures (32%) and urinalyses (30%); the most commonly prescribed medications were antibiotics (32%) and alpha-1 blockers (15%). These are appropriate tests and medications for this study's most frequently identified urinary dysfunction diagnoses. The management of urinary dysfunction includes interventions such as education, lifestyle advice [32], facilitative techniques, rehabilitation, catheterizations, and pharmacologic treatment [13] (as noted in our study in Table 2), and surgery may also be required [13]. In our study population, no surgical intervention was warranted, even for patients who required urology consultations. Specialists (from the departments of urology, nephrology, infectious diseases, and internal medicine) were consulted in 7 (15%) cases. These findings highlight the need for possible multimodal and interdisciplinary approaches to managing acute urinary dysfunction.
The factors associated with acute urinary dysfunction were surgery during the index admission, a longer inpatient rehabilitation length of stay, and fecal incontinence during acute inpatient rehabilitation. Surgery has been known to be associated with symptoms of urinary dysfunction, such as urinary retention [33] and urinary tract infections [34]. Postoperative urinary tract infections have been associated with longer hospital stays [35]. Finally, the clinical comorbidity between bladder and bowel dysfunction has been demonstrated in many reports [36]. There are many correlations between the lower urinary and gastrointestinal tracts, such as their embryological origins, anatomical positions in the pelvis, use of the same supporting muscles, joint peripheral innervation and coordination of viscera, and similar functions of storing and evacuating waste [36].
This small, retrospective study was conducted at a single institution in a full-service academic medical center to describe the characteristics of acute urinary dysfunction in the specific setting of acute inpatient cancer rehabilitation. Retrospective by nature would depend on the data available to collect and analyze. Thus, other unaccounted risk factors could have confounded the results. The generalizability of our findings to other facilities' acute inpatient cancer rehabilitation services may be limited owing to the differences in referral patterns to an acute inpatient rehabilitation facility.
Despite these limitations, this study fills a knowledge gap and highlights the importance of assessing for acute urinary dysfunction among patients with cancer undergoing inpatient rehabilitation. The information it provides regarding the nature and management of acute urinary dysfunction in patients with cancer can be helpful to clinicians and consultants involved in rehabilitation settings providing comprehensive and interdisciplinary care. The data can also be used to convince payors to authorize the transfer of medically complex patients, such as these patients with cancer at risk for urinary dysfunction, to acute inpatient rehabilitation as opposed to subacute rehabilitation settings (i.e., skilled nursing facilities, long-term acute care hospitals), in which resources for managing urological complications may be limited.
In this study, we found acute urinary dysfunction among more than a quarter of the patients with cancer undergoing acute inpatient rehabilitation. Acute urinary dysfunction was associated with a longer inpatient rehabilitation length of stay, surgery during the index admission, and fecal incontinence. There should be a low threshold of suspicion for acute urinary dysfunction in patients with cancer after hospitalization and admitted for acute inpatient rehabilitation. Urinary symptoms should be closely monitored for medical and symptom management and to improve patients' independence with bladder care. Further research regarding acute urinary dysfunction in patients with cancer in other settings globally is needed to understand the nature, frequency, and management patterns.
AM-PAC: Activity Measure for Post-Acute Care; CI: confidence intervals.
With written consent, we thank Aline Rozman de Moraes, MD, and Maria Guerra-Sanchez, BSN, RN, in the Department of Palliative, Rehabilitation, and Integrative Medicine for partial data collection and preparation. We also thank the Research Medical Library at The University of Texas MD Anderson Cancer Center for providing editing services.
This study used The University of Texas MD Anderson Cancer Center's Biostatistics Shared Resource, partly supported by the National Institutes of Health/National Cancer Institute under the Cancer Center Support Grant P30 CA016672.
The abstract will be presented as a poster at the Association of Academic Physiatrists Annual Meeting in Anaheim, CA, in February 2023.
The data supporting this study's findings are available from the corresponding author upon reasonable request.
Jegy Tennison: conception and design, provision of study material or patients, data collection, data analysis and interpretation, manuscript writing, and final approval.
Annie Pally: data collection, analysis and interpretation, manuscript writing, and final approval.
Bryan Fellman: statistical analysis, manuscript writing, and final approval.
Ouida L. Westney: data interpretation, manuscript writing, and final approval.
Eduardo Bruera: conception and design, data analysis and interpretation, manuscript writing, and final approval.
The authors have declared that no competing interest exists.
1. Moussa M, Papatsoris A, Chakra MA, Fares Y, Dellis A. Lower Urinary Tract Dysfunction in Common Neurological Diseases. Turkish journal of urology. 2020;46(Supp. 1):S70-s78
2. McVary KT, Saini R. Lower Urinary Tract Symptoms in Men. In: Givens J, Eckler K, ed. UpToDate. Waltham, MA: UpToDate. 2018 https://www.uptodate.com/contents/lower-urinary-tract-symptoms-in-males
3. Truzzi JC, de Almeida FG, Sacomani CA, Reis J, Rocha FET. Neurogenic Bladder - Concepts and Treatment Recommendations. International braz j urol: official journal of the Brazilian Society of Urology. 2022;48(2):220-243
4. Agarwal A, Eryuzlu LN, Cartwright R. et al. What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women. Eur Urol. 2015;65(6):1211-1217
5. Coyne KS, Wein A, Nicholson S, Kvasz M, Chen C-I, Milsom I. Economic Burden of Urgency Urinary Incontinence in the United States: A Systematic Review. Journal of Managed Care Pharmacy. 2014;20(2):130-140
6. Abedi A, Sayegh Aref S, Ha Nhi T. et al. Health Care Economic Burden of Treatment and Rehabilitation for Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. The Journal of urology. 2022;208(4):773-783
7. Cancer.net. Urinary Incontinence. 2021. https://www.cancer.net/coping-with-cancer/physical-emotional-and-social-effects-cancer/managing-physical-side-effects/urinary-incontinence.
8. National Cancer Institute. Urinary and Bladder Problems. 2020. https://www.cancer.gov/about-cancer/treatment/side-effects/urination-changes.
9. Boushey R. Management of Intra-Abdominal, Pelvic, and Genitourinary Complications of Colorectal Surgery. In: Weiser M, ed. UpToDate. Waltham, MA: Up to Date. 2022 https://www.uptodate.com/contents/management-of-intra-abdominal-pelvic-and-genitourinary-complications-of-colorectal-surgery?search=urinary%20incontinence%20rectal%20surgery§ionRank=2&usage_type=default&anchor=H98515613&source=machineLearning&selectedTitle=1~150&display_rank=1#H98515613
10. Klein EA. Radical prostatectomy for localized prostate cancer. In: Chen W, ed. Waltham, MA: UpToDate. 2022 https://www.uptodate.com/contents/radical-prostatectomy-for-localized-prostate-cancer?search=Urinary%20Incontinence%20After%20Prostate%20Treatment&topicRef=15176&source=see_link
11. Opławski M, Grabarek BO, Średnicka A. et al. The Impact of Surgical Treatment with Adjuvant Chemotherapy for Ovarian Cancer on Disorders in the Urinary System and Quality of Life in Women. Journal of Clinical Medicine. 2022;11(5):1300
12. Opławski M, Smoczyńska M, Grabarek BO, Boroń D. Assessment of Dysfunction in the Urinary System as Well as Comfort in the Life of Women during and after Combination Therapy Due to Ovarian and Endometrial Cancer Based on the SWL, II-Q7 and UDI-6 Scales. Journal of Clinical Medicine. 2021;10(6):1228
13. Emedicine. Bladder Dysfunction Treatment & Management. 2018. https://emedicine.medscape.com/article/321273-treatment.
14. Nseyo U, Santiago-Lastra Y. Long-Term Complications of the Neurogenic Bladder. Urol Clin North Am. 2017;44(3):355-366
15. Saotome T, Klein L, Faux S. Cancer Rehabilitation: A Barometer for Survival? Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2015;23(10):3033-3041
16. Tennison JM, Fricke BC, Fu JB, Patel TA, Chen M, Bruera E. Medical Complications and Prognostic Factors for Medically Unstable Conditions During Acute Inpatient Cancer Rehabilitation. JCO oncology practice. 2021;17(10):e1502-1511
17. Jette DU, Stilphen M, Ranganathan VK, Passek SD, Frost FS, Jette AM. Validity of the AM-PAC “6-Clicks” Inpatient Daily Activity and Basic Mobility Short Forms. Physical therapy. 2014;94(3):379-391
18. Jette DU, Stilphen M, Ranganathan VK, Passek S, Frost FS, Jette AM. Interrater Reliability of AM-PAC "6-Clicks" Basic Mobility and Daily Activity Short Forms. Physical therapy. 2015;95(5):758-766
19. Pizzi A, Falsini C, Martini M, Rossetti MA, Verdesca S, Tosto A. Urinary Incontinence after Ischemic Stroke: Clinical and Urodynamic Studies. Neurourology and urodynamics. 2014;33(4):420-425
20. Kulaklı F, Koklu K, Ersoz M, Ozel S. Relationship Between Urinary Dysfunction and Clinical Factors in Patients with Traumatic Brain Injury. Brain injury. 2014;28(3):323-327
21. Leary SM, Liu C, Cheesman AL, Ritter A, Thompson S, Greenwood R. Incontinence After Brain Injury: Prevalence, Outcome and Multidisciplinary Management on a Neurological Rehabilitation Unit. Clinical rehabilitation. 2006;20(12):1094-1099
22. Elliott CS, Kopp MA, Stampas A. et al. The Effect of Early Infection on the Rate of Volitional Voiding after Spinal Cord Injury: A Potential Modifiable Risk Factor for Bladder Outcomes. The Journal of urology. 2022;207(1):137-143
23. Anderson CE, Chamberlain JD, Jordan X. et al. Bladder Emptying Method is the Primary Determinant of Urinary Tract Infections in Patients with Spinal Cord Injury: Results from a Prospective Rehabilitation Cohort Study. BJU Int. 2019;123(2):342-352
24. Teo CP, Cheng K, New PW. Retrospective Study of Functional Outcomes and Disability after Non-Ischaemic Vascular Causes of Spinal Cord Dysfunction. The journal of spinal cord medicine. 2021;44(2):306-311
25. Tennison JM, Sullivan CM, Fricke BC, Bruera E. Analysis of Adherence to Acute Inpatient Rehabilitation in Patients with Cancer. Journal of Cancer. 2021;12(20):5987-5990
26. Tennison JM, Rianon NJ, Manzano JG, Munsell MF, George MC, Bruera E. Thirty-day Hospital Readmission Rate, Reasons, and Risk Factors after Acute Inpatient Cancer Rehabilitation. Cancer medicine. 2021;10(18):6199-6206
27. Mix JM, Granger CV, LaMonte MJ. et al. Characterization of Cancer Patients in Inpatient Rehabilitation Facilities: A Retrospective Cohort Study. Archives of physical medicine and rehabilitation. 2017;98(5):971-980
28. Taweel WA, Seyam R. Neurogenic Bladder in Spinal Cord Injury Patients. Research and reports in urology. 2015;7:85-99
29. Stampas A, Dominick E, Zhu L. Evaluation of Functional Outcomes in Traumatic Spinal Cord Injury with Rehabilitation-Acquired Urinary Tract Infections: A Retrospective Study. The journal of spinal cord medicine. 2019;42(5):579-585
30. Hong KS, Kang DW, Koo JS. et al. Impact of Neurological and Medical Complications on 3-month Outcomes in Acute Ischaemic Stroke. European journal of neurology. 2008;15(12):1324-1331
31. Pape TL-B, Lundgren S, Heinemann AW. et al. Establishing a Prognosis for Functional Outcome During Coma Recovery. Brain injury. 2006;20(7):743-758
32. Oelke M, Bachmann A, Descazeaud A. et al. EAU Guidelines on the Treatment and Follow-up of Non-Neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol. 2013;64(1):118-140
33. Pomajzl AJ, Siref LE. Post-op Urinary Retention. Treasure Island (FL): StatPearls. 2022 https://www.ncbi.nlm.nih.gov/books/NBK549844/
34. Stéphan F, Sax H, Wachsmuth M, Hoffmeyer P, Clergue F, Pittet D. Reduction of Urinary Tract Infection and Antibiotic Use after Surgery: A Controlled, Prospective, Before-After Intervention Study. Clin Infect Dis. 2006;42(11):1544-1551
35. Alvarez AP, Demzik AL, Alvi HM, Hardt KD, Manning DW. Risk Factors for Postoperative Urinary Tract Infections in Patients Undergoing Total Joint Arthroplasty. Advances in orthopedics. 2016;2016:7268985
36. Malykhina AP, Wyndaele JJ, Andersson KE, De Wachter S, Dmochowski RR. Do the Urinary Bladder and Large Bowel Interact, in Sickness or in Health? ICI-RS 2011. Neurourology and urodynamics. 2012;31(3):352-358
Corresponding author: Jegy M. Tennison, MD, Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1414, Houston, TX 77030. Phone: (713) 745-2327; Fax: 713-792-6092; E-mail: jmtennisonorg.
Received 2022-11-8
Accepted 2022-12-25
Published 2023-1-9